Tavipek capsules 0.15 g. №30


Manufacturer: Austria



Composition and form of release
Main active ingredients: 1 capsule contains 150 mg of lavender essential oil.
Auxiliary components: gelatin, glycerin, quinoline yellow, sunset yellow, methacrylate copolymer (type A), sodium lauryl sulfate, propylene glycol, polysorbate, glycerin monostearate.
Pharmacological properties
This pharmacological drug belongs to the group of drugs used for coughs and colds, is an expectorant.
The drug has secretolytic, expectorant, mucolytic, epithelizing, anti-inflammatory, antimicrobial, immunostimulating activity. The secretolytic effect of the drug is that it increases mucociliary clearance.
Mucolytic and expectorant effects are due to the drug’s ability to thin mucus and enhance the functional activity of the ciliated epithelium.
The use of the drug helps to quickly and easily free the respiratory tract from mucus. The antimicrobial and anti-inflammatory effects of the drug are caused by bactericidal and anti-inflammatory activity, and are expressed in suppressing the growth of bacteria.
The active ingredient deactivates staphylococcus toxin – alpha-hemolysin and streptococcal toxin – streptolysin, which are secreted by pathogenic bacteria.
The medicine potentiates the immune elements by activating cellular immunity, increasing phagocytic leukocyte activity.
The bioavailability of the drug does not change when used simultaneously with 1,8-cineole in the form of enteric capsules, which are labeled with an atom of lavender essential oil, even with a long residence time in the gastrointestinal tract.
The drug is prescribed to treat the following symptoms of ARVI and ARI:

  • acute bronchitis;
  • Chronical bronchitis;
  • bronchectasis;
  • smoker’s cough;
  • sinusitis.

The drug in question is contraindicated for use in cases where the patient has severe hypersensitivity (allergy) to the main or to one of the auxiliary components.
The drug is contraindicated for the following diseases:

  • peptic ulcer;
  • hyperacid gastritis;
  • acute hepatitis;
  • pancreatitis;
  • nephritis.

In pediatrics, the drug is used after 12 years.
Application during pregnancy and lactation
This drug is not recommended for pregnant women – only for strict indications determined by the attending physician.
If it is necessary to take the drug during breastfeeding, lactation is suspended.
Method of administration and dosage
Adults and children over 12 years old take 1-2 capsules 3 times a day, do not chew, with meals.
The course of therapy depends on the nature and severity of the disease and is determined by the doctor individually.
Overdose cases are not described. Nausea and other gastrointestinal complaints are suspected.
Side effects
The drug is usually well tolerated if used in the recommended doses and the regimen is followed.
Allergy may occur in case of individual intolerance. In particular, there may be observed:

  • belching, short-term nausea, vomiting, abdominal pain, dysgeusia;
  • allergic reactions, including skin rashes, hives;
  • the smell of lavender oil is likely on exhalation.

Storage conditions and periods
Expiration date – up to 3 years from the production date indicated on the package. Storage periods should not be exceeded.
Storage temperature should not exceed 30 ° C. Temperature deviations can change the properties of the preparation, therefore it should always be stored in its original packaging.